BIO:NYSE
Bio-Rad Laboratories, Inc. Class A Common Stock
$ 362.43
arrow_downward
-0.36%(-1.30) 1D
10-р сарын 14, 16:00:04 (GMT-4) · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BIO...
Open
$ 367.86
High
$ 371.07
Low
$ 361.26
Mkt. cap
9.70 тэрбум
Avg. vol.
253.41 мян
Volume
198.69 мян
P/E ratio
43.94
52-wk high
$ 396.23
52-wk low
$ 236.73
EPS
$ 8.25
Beta
1.07
Shares outstanding
21.68 сая
No. of employees
7 мян
Open
$ 367.86
High
$ 371.07
Low
$ 361.26
Mkt. cap
9.70 тэрбум
Avg. vol.
253.41 мян
Volume
198.69 мян
P/E ratio
43.94
52-wk high
$ 396.23
52-wk low
$ 236.73
EPS
$ 8.25
Beta
1.07
Shares outstanding
21.68 сая
No. of employees
7 мян
News stories
From web sources and news partners
Business Wire
·
7 цагийн өмнө
Bio-Rad to Report Third-Quarter 2026 Financial Results on Wednesday, November 4, 2026
Profile
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California, by husband and wife team David and Alice Schwartz, both graduates of the University of California, Berkeley. Bio-Rad is based in Hercules, California, and has operations worldwide. Wikipedia
About Bio-Rad Laboratories, Inc. Class A Common Stock
CEONorman David Schwartz
Employees7.45 мян
Founded1952
HeadquartersHercules, Калифорни, Америкийн Нэгдсэн Улс
SectorHealth care
Websitebio-rad.com